Logo image of CSGP

COSTAR GROUP INC (CSGP) Stock Fundamental Analysis

NASDAQ:CSGP - US22160N1090 - Common Stock

91.22 USD
+2.86 (+3.24%)
Last: 8/22/2025, 8:00:59 PM
91.25 USD
+0.03 (+0.03%)
After Hours: 8/22/2025, 8:00:59 PM
Fundamental Rating

5

CSGP gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 64 industry peers in the Real Estate Management & Development industry. CSGP has an average financial health and profitability rating. CSGP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year CSGP was profitable.
CSGP had a positive operating cash flow in the past year.
Each year in the past 5 years CSGP has been profitable.
Each year in the past 5 years CSGP had a positive operating cash flow.
CSGP Yearly Net Income VS EBIT VS OCF VS FCFCSGP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

CSGP has a Return On Assets of 0.99%. This is in the better half of the industry: CSGP outperforms 68.75% of its industry peers.
CSGP's Return On Equity of 1.21% is fine compared to the rest of the industry. CSGP outperforms 67.19% of its industry peers.
Industry RankSector Rank
ROA 0.99%
ROE 1.21%
ROIC N/A
ROA(3y)3.37%
ROA(5y)3.48%
ROE(3y)4.11%
ROE(5y)4.33%
ROIC(3y)N/A
ROIC(5y)N/A
CSGP Yearly ROA, ROE, ROICCSGP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

CSGP has a better Profit Margin (3.57%) than 76.56% of its industry peers.
CSGP's Profit Margin has declined in the last couple of years.
CSGP's Operating Margin has declined in the last couple of years.
The Gross Margin of CSGP (79.33%) is better than 92.19% of its industry peers.
In the last couple of years the Gross Margin of CSGP has remained more or less at the same level.
Industry RankSector Rank
OM N/A
PM (TTM) 3.57%
GM 79.33%
OM growth 3Y-80.23%
OM growth 5Y-63.35%
PM growth 3Y-30.42%
PM growth 5Y-25.78%
GM growth 3Y-0.84%
GM growth 5Y0.06%
CSGP Yearly Profit, Operating, Gross MarginsCSGP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

6

2. Health

2.1 Basic Checks

CSGP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CSGP has been increased compared to 1 year ago.
Compared to 5 years ago, CSGP has more shares outstanding
The debt/assets ratio for CSGP has been reduced compared to a year ago.
CSGP Yearly Shares OutstandingCSGP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CSGP Yearly Total Debt VS Total AssetsCSGP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

CSGP has an Altman-Z score of 13.16. This indicates that CSGP is financially healthy and has little risk of bankruptcy at the moment.
CSGP has a Altman-Z score of 13.16. This is amongst the best in the industry. CSGP outperforms 89.06% of its industry peers.
CSGP has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
CSGP's Debt to Equity ratio of 0.12 is fine compared to the rest of the industry. CSGP outperforms 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 13.16
ROIC/WACCN/A
WACC8.73%
CSGP Yearly LT Debt VS Equity VS FCFCSGP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 5.83 indicates that CSGP has no problem at all paying its short term obligations.
CSGP's Current ratio of 5.83 is amongst the best of the industry. CSGP outperforms 89.06% of its industry peers.
CSGP has a Quick Ratio of 5.83. This indicates that CSGP is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 5.83, CSGP belongs to the best of the industry, outperforming 92.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.83
Quick Ratio 5.83
CSGP Yearly Current Assets VS Current LiabilitesCSGP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

6

3. Growth

3.1 Past

The earnings per share for CSGP have decreased by -5.68% in the last year.
The Earnings Per Share has been decreasing by -6.71% on average over the past years.
The Revenue has grown by 12.18% in the past year. This is quite good.
The Revenue has been growing by 14.35% on average over the past years. This is quite good.
EPS 1Y (TTM)-5.68%
EPS 3Y-14.08%
EPS 5Y-6.71%
EPS Q2Q%13.33%
Revenue 1Y (TTM)12.18%
Revenue growth 3Y12.07%
Revenue growth 5Y14.35%
Sales Q2Q%15.27%

3.2 Future

The Earnings Per Share is expected to grow by 33.96% on average over the next years. This is a very strong growth
Based on estimates for the next years, CSGP will show a quite strong growth in Revenue. The Revenue will grow by 12.54% on average per year.
EPS Next Y14.17%
EPS Next 2Y38.19%
EPS Next 3Y41.22%
EPS Next 5Y33.96%
Revenue Next Year15.14%
Revenue Next 2Y13.98%
Revenue Next 3Y13.74%
Revenue Next 5Y12.54%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CSGP Yearly Revenue VS EstimatesCSGP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
CSGP Yearly EPS VS EstimatesCSGP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

CSGP is valuated quite expensively with a Price/Earnings ratio of 109.90.
Based on the Price/Earnings ratio, CSGP is valued a bit cheaper than the industry average as 60.94% of the companies are valued more expensively.
CSGP's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.24.
With a Price/Forward Earnings ratio of 66.35, CSGP can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, CSGP is valued a bit cheaper than 68.75% of the companies in the same industry.
CSGP is valuated expensively when we compare the Price/Forward Earnings ratio to 35.82, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 109.9
Fwd PE 66.35
CSGP Price Earnings VS Forward Price EarningsCSGP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CSGP.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 195.29
CSGP Per share dataCSGP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CSGP does not grow enough to justify the current Price/Earnings ratio.
CSGP's earnings are expected to grow with 41.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)7.76
PEG (5Y)N/A
EPS Next 2Y38.19%
EPS Next 3Y41.22%

More info and screens

0

5. Dividend

5.1 Amount

CSGP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COSTAR GROUP INC

NASDAQ:CSGP (8/22/2025, 8:00:59 PM)

After market: 91.25 +0.03 (+0.03%)

91.22

+2.86 (+3.24%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)07-22 2025-07-22/amc
Earnings (Next)10-20 2025-10-20/amc
Inst Owners105.81%
Inst Owner Change-0.75%
Ins Owners0.69%
Ins Owner Change-0.05%
Market Cap38.65B
Analysts80
Price Target97.74 (7.15%)
Short Float %3.79%
Short Ratio5.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)56.04%
Min EPS beat(2)21.03%
Max EPS beat(2)91.05%
EPS beat(4)4
Avg EPS beat(4)39.69%
Min EPS beat(4)13.92%
Max EPS beat(4)91.05%
EPS beat(8)7
Avg EPS beat(8)33.64%
EPS beat(12)11
Avg EPS beat(12)25.84%
EPS beat(16)15
Avg EPS beat(16)23.56%
Revenue beat(2)0
Avg Revenue beat(2)-1.23%
Min Revenue beat(2)-1.67%
Max Revenue beat(2)-0.8%
Revenue beat(4)0
Avg Revenue beat(4)-1.5%
Min Revenue beat(4)-2.45%
Max Revenue beat(4)-0.8%
Revenue beat(8)0
Avg Revenue beat(8)-1.51%
Revenue beat(12)0
Avg Revenue beat(12)-1.63%
Revenue beat(16)0
Avg Revenue beat(16)-1.54%
PT rev (1m)6.76%
PT rev (3m)8.66%
EPS NQ rev (1m)-13.24%
EPS NQ rev (3m)-33.21%
EPS NY rev (1m)0.95%
EPS NY rev (3m)-5.19%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)6.03%
Revenue NY rev (1m)0.38%
Revenue NY rev (3m)0.34%
Valuation
Industry RankSector Rank
PE 109.9
Fwd PE 66.35
P/S 13.26
P/FCF N/A
P/OCF 97.94
P/B 4.49
P/tB 9.67
EV/EBITDA 195.29
EPS(TTM)0.83
EY0.91%
EPS(NY)1.37
Fwd EY1.51%
FCF(TTM)0
FCFYN/A
OCF(TTM)0.93
OCFY1.02%
SpS6.88
BVpS20.3
TBVpS9.43
PEG (NY)7.76
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.99%
ROE 1.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.57%
GM 79.33%
FCFM N/A
ROA(3y)3.37%
ROA(5y)3.48%
ROE(3y)4.11%
ROE(5y)4.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3%
ROCE(5y)3.93%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-80.23%
OM growth 5Y-63.35%
PM growth 3Y-30.42%
PM growth 5Y-25.78%
GM growth 3Y-0.84%
GM growth 5Y0.06%
F-Score5
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA 5.52
Cap/Depr 211.14%
Cap/Sales 13.59%
Interest Coverage N/A
Cash Conversion 217.65%
Profit Quality N/A
Current Ratio 5.83
Quick Ratio 5.83
Altman-Z 13.16
F-Score5
WACC8.73%
ROIC/WACCN/A
Cap/Depr(3y)211.68%
Cap/Depr(5y)162.35%
Cap/Sales(3y)11.14%
Cap/Sales(5y)9.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.68%
EPS 3Y-14.08%
EPS 5Y-6.71%
EPS Q2Q%13.33%
EPS Next Y14.17%
EPS Next 2Y38.19%
EPS Next 3Y41.22%
EPS Next 5Y33.96%
Revenue 1Y (TTM)12.18%
Revenue growth 3Y12.07%
Revenue growth 5Y14.35%
Sales Q2Q%15.27%
Revenue Next Year15.14%
Revenue Next 2Y13.98%
Revenue Next 3Y13.74%
Revenue Next 5Y12.54%
EBIT growth 1Y-108.74%
EBIT growth 3Y-77.85%
EBIT growth 5Y-58.09%
EBIT Next Year3050.45%
EBIT Next 3Y337.87%
EBIT Next 5Y157.07%
FCF growth 1Y-100.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.15%
OCF growth 3Y-5.8%
OCF growth 5Y-3.03%